# Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery

> **NCT02984111** · NA · COMPLETED · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 97 (actual)

## Conditions studied

- Myocardial Ischemic Reperfusion Injury

## Interventions

- **DRUG:** normal saline
- **DRUG:** erythropoietin

## Key facts

- **NCT ID:** NCT02984111
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-06
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2017-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02984111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02984111, "Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02984111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*